SCHEMBL12818994

SCHEMBL12818994

Cc1nc2cc(S(=O)(=O)N3CCOc4ccc(-c5ccc(C#N)[nH]5)cc43)ccc2o1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 1/20 0.39
▸ CYP2C9 P11712 2/20 0.38
▸ PDE3B Q13370 4/20 0.36
▸ PDE3A Q14432 4/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ MEN1 O00255 4/20 0.35
▸ KMT2A Q03164 4/20 0.35
▸ MAPT P10636 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.34
▸ CPT1A P50416 2/20 0.34
▸ CPT1B Q92523 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ CPT2 P23786 1/20 0.34
▸ PKM P14618 1/20 0.33
▸ PKLR P30613 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12818652 0.83 MEN1 (0.40) CYP2C9PDE3BPDE3ANPC1MEN1
SCHEMBL12818498 0.83 PKM (0.41) CYP2C9PDE3BPDE3ANPC1MEN1
SCHEMBL12817769 0.83 CYP2C9 (0.38) CYP2C9PDE3BPDE3ANPC1MEN1
SCHEMBL12817667 0.83 PGR (0.39) PGRCYP2C9PDE3BPDE3ANPC1
SCHEMBL12818698 0.81 CYP2C9 (0.37) CYP2C9PDE3BPDE3ANPC1MEN1
SCHEMBL12818998 0.80 PKM (0.39) PGRCYP2C9PDE3BPDE3ANPC1
SCHEMBL1818453 0.80 PDE3B (0.39) PGRCYP2C9PDE3BPDE3ANPC1
SCHEMBL12818499 0.79 PKM (0.42) PGRCYP2C9PDE3BPDE3ANPC1
SCHEMBL12818304 0.79 PKM (0.43) CYP2C9PDE3BPDE3ANPC1MEN1
SCHEMBL12818134 0.78 CYP2C9 (0.40) CYP2C9PDE3BPDE3ANPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO claimed
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO disclosed
Send feedback